Association of Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement with Unplanned Hospitalization for Head and Neck Cancer
Authors:
- Sung Jun MaSMSung Jun Ma
- Jas VirkJVJas Virk
- Tyler V. SchrandTSTyler V. Schrand
- Jasmin GillJGJasmin Gill
- Neil AlmeidaNANeil Almeida
- Harshini K. CheruvuHCHarshini K. Cheruvu
- Vishal GuptaVGVishal Gupta
- Kimberly E. WootenKWKimberly E. Wooten
- Moni A. KuriakoseMKMoni A. Kuriakose
- Michael R. MarkiewiczMMMichael R. Markiewicz
- Ryan P. McSpaddenRMRyan P. McSpadden
- Wesley L. HicksWHWesley L. Hicks
Open Access
Abstract
Background/Objectives: There is a varying need for nutritional support among head and neck cancer (HNC) patients. Unplanned hospitalization is frequent with definitive chemoradiation. However, the association of unplanned hospitalizations with cancer control outcomes and percutaneous endoscopic gastrostomy (PEG) tube placement is not well-understood. This study aims to evaluate the clinical outcomes stratified by unplanned hospitalizations and to identify the prognostic factors associated with unplanned hospitalizations. Methods: This retrospective cohort study included 657 HNC patients treated with definitive chemoradiation at a single institution between 2007 and 2023. Relevant clinical data were evaluated for unplanned hospitalizations, prophylactic vs. therapeutic PEG tube placement, and clinical outcomes. Multivariable, subgroup, and matched-pair analyses were performed to account for potential confounding variables. The main outcomes and measures used are overall survival (OS), progression-free survival (PFS), locoregional failure (LRF), distant failure (DF), and incidence of unplanned hospitalization. Results: Unplanned hospitalizations occurred in 190 (29%) patients, which were associated with worse OS (adjusted hazards ratio [aHR] of 2.07, 95% confidence interval [CI] of 1.53–2.81, p < 0.001) and progression-free survival (aHR 1.83, 95% CI 1.38–2.41, p < 0.001). However, hospitalizations were not associated with LRF or DF outcomes. Similar findings were noted on 180 matched pairs as well as subgroups stratified by p16 status. In addition, when compared to patients with a prophylactic PEG tube, therapeutic PEG tube placement was associated with a higher risk of hospitalization (adjusted odds ratio [aOR] of 1.96, 95% CI 1.10–3.54, p = 0.02), while those without PEG tubes were less likely to be hospitalized (aOR 0.48, 95% CI 0.27–0.86, p = 0.01). Conclusions: Unplanned hospitalization was an independent, adverse prognostic factor for poor survival, but not oncologic outcomes. Unplanned hospitalization incidence was largely driven by those who required a therapeutic PEG tube, while it was the lowest for those who never needed a PEG tube.Keywords
Funding Information
- National Cancer Institute Cancer Center Support Grant (P30CA016056)
This publication has 30 references indexed in Scilit:
- Weekly Cisplatin Cycles and Outcomes for Chemoradiation in Head and Neck CancerJAMA Network Open, 2024
- Machine Learning–Based Prediction of Hospitalization During Chemoradiotherapy With Daily Step CountsJAMA Oncology, 2024
- Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry AnalysisOtolaryngology–Head and Neck Surgery, 2024
- Impact of pretreatment body mass index on the survival of head and neck cancer patientsHead & Neck, 2024
- Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck CancerJAMA Network Open, 2023
- Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With ChemoradiotherapyJAMA Network Open, 2023
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- Intensive Chemoradiotherapy as a Primary Treatment for Organ Preservation in Patients With Advanced Cancer of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 2004
- Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapySupportive Care in Cancer, 2002
- Prophylactic Gastrostomy Tubes in Patients Undergoing Intensive Irradiation for Cancer of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 1998